These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1413197)

  • 21. [Hallucinogenic mushrooms popular again--sale via Internet].
    Westberg U; Karlson-Stiber C
    Lakartidningen; 1999 Feb; 96(7):746-7. PubMed ID: 10087778
    [No Abstract]   [Full Text] [Related]  

  • 22. Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016.
    Leonard JB; Anderson B; Klein-Schwartz W
    J Psychopharmacol; 2018 Dec; 32(12):1286-1294. PubMed ID: 30182795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hallucinogenic mushrooms in Mississippi.
    Jacobs KW
    J Miss State Med Assoc; 1975 Feb; 16(2):35-7. PubMed ID: 1089159
    [No Abstract]   [Full Text] [Related]  

  • 24. Hallucinogenic mushrooms on the German market - simple instructions for examination and identification.
    Musshoff F; Madea B; Beike J
    Forensic Sci Int; 2000 Sep; 113(1-3):389-95. PubMed ID: 10978653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Narcotic mushrooms with LSD?].
    Stahl E; Brombeer J; Eskes D
    Arch Kriminol; 1978; 162(1-2):23-33. PubMed ID: 567963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intoxications by hallucinogenic mushrooms].
    Pierrot M; Josse P; Raspiller MF; Goulmy M; Rambourg MO; Manel J; Lambert H
    Ann Med Interne (Paris); 2000 Oct; 151 Suppl B():B16-9. PubMed ID: 11104939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psilocybin--summary of knowledge and new perspectives.
    Tylš F; Páleníček T; Horáček J
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):342-56. PubMed ID: 24444771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poisonings resulting from the ingestion of magic mushrooms in Kraków.
    Satora L; Goszcz H; Ciszowski K
    Przegl Lek; 2005; 62(6):394-6. PubMed ID: 16225077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pharmacology of psilocybin.
    Passie T; Seifert J; Schneider U; Emrich HM
    Addict Biol; 2002 Oct; 7(4):357-64. PubMed ID: 14578010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Psychoactive mushrooms - an update].
    Supprian T; Frey U; Supprian R; Rösler M; Wanke K
    Fortschr Neurol Psychiatr; 2001 Dec; 69(12):597-602. PubMed ID: 11753749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The impact of psilocybin on visual perception and spatial orientation--neuropsychological approach].
    Jastrzebski M; Bala A
    Psychiatr Pol; 2013; 47(6):1157-67. PubMed ID: 25007546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users.
    McCambridge J; Winstock A; Hunt N; Mitcheson L
    Eur Addict Res; 2007; 13(1):57-64. PubMed ID: 17172780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toward a typology of hallucinogen users in the United States.
    Salas-Wright CP; Hodges JC; Hai AH; Alsolami A; Vaughn MG
    Drug Alcohol Depend; 2021 Dec; 229(Pt B):109139. PubMed ID: 34781182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Suicide under the influence of "magic mushrooms"].
    Müller K; Püschel K; Iwersen-Bergmann S
    Arch Kriminol; 2013; 231(5-6):193-8. PubMed ID: 23878898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Student's use of illicit drugs: a survey in a preventive health service].
    Morvan Y; Rouvier J; Olié JP; Lôo H; Krebs MO
    Encephale; 2009 Dec; 35 Suppl 6():S202-8. PubMed ID: 20141772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms.
    Barrett FS; Bradstreet MP; Leoutsakos JS; Johnson MW; Griffiths RR
    J Psychopharmacol; 2016 Dec; 30(12):1279-1295. PubMed ID: 27856683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Microscopic study of powders of hallucinogenic mushrooms--Psilocybe sp].
    Schäfer AT
    Arch Kriminol; 2000; 205(1-2):30-6. PubMed ID: 10726173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psilocybin mushroom (Psilocybe semilanceata) intoxication with myocardial infarction.
    Borowiak KS; Ciechanowski K; Waloszczyk P
    J Toxicol Clin Toxicol; 1998; 36(1-2):47-9. PubMed ID: 9541042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening of hallucinogenic mushrooms with high-performance liquid chromatography and multiple detection.
    Christiansen AL; Rasmussen KE
    J Chromatogr; 1983 Nov; 270():293-9. PubMed ID: 6686235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hallucinogenic mushrooms and psilocybine].
    DEYSSON G
    Proc Pharm Soc Egypt; 1960 Jan; 15():27-9. PubMed ID: 24546366
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.